Sleeping sickness in travelers - do they really sleep?

PLoS Neglected Tropical Diseases

Volumn 5, Issue 11, 2011, Pages

  Urech, Karin ^a,b   Neumayr, Andreas ^a   Blum, Johannes ^a  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EFLORNITHINE; MELARSOPROL; PENTAMIDINE; SURAMIN;

ADULT; AFRICAN TRYPANOSOMIASIS; ARTICLE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ERROR; ENDEMIC DISEASE; FEMALE; FEVER; GEOGRAPHIC DISTRIBUTION; HALLUCINATION; HEADACHE; HUMAN; INSOMNIA; JAUNDICE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PSYCHOMOTOR DISORDER; REFLEX DISORDER; SOMNOLENCE; SPECIES DIFFERENTIATION; SYPHILIS; TRAVEL; TRYPANOSOMA GAMBIENSE; TRYPANOSOMA RHODESIENSE; PATHOLOGY; SKIN ULCER;

ADULT; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FEVER; HEADACHE; HUMANS; JAUNDICE; MALE; SKIN ULCER; SLEEP INITIATION AND MAINTENANCE DISORDERS; TRAVEL; TRYPANOSOMIASIS, AFRICAN;

EID: 82555184832     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0001358     Document Type: Article

References (42)

1. WHO (1998) Control and Surveillance of African Trypanosomiasis. WHO Technical rapport.
2. Blum J, Schmid C, Burri C, (2006) Clinical aspects of 2541 patients with second stage human African trypanosomiasis. Acta Trop 97: 55-64.
3. MacLean LM, Odiit M, Chisi JE, Kennedy PG, Sternberg JM, (2010) Focus-specific clinical profiles in human African Trypanosomiasis caused by Trypanosoma brucei rhodesiense. PLoS Negl Trop Dis 4: e906.
4. Heppner C, Petzke F, Arlt W, Mbulamberi D, Siekmann L, et al. (1995) Adrenocortical insufficiency in Rhodesian sleeping sickness is not attributable to suramin. Trans R Soc Trop Med Hyg 89: 65-68.
5. Mbulamberi DB, (1987) A clinical analysis of 3151 cases of Rhodesian sleeping sickness treated in the South Eastern Uganda, during the year 1985 pp. 188-195.
6. Duggan AJ, Hutchinson MP, (1966) Sleeping sickness in Europeans: a review of 109 cases. J Trop Med Hyg 69: 124-131.
7. Ezzedine K, Darie H, Le Bras M, Malvy D, (2007) Skin features accompanying imported human African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations. J Travel Med 14: 192-196.
8. Blum J, Burri C, (2002) Treatment of late stage sleeping sickness caused by T.b. gambiense: a new approach to the use of an old drug. Swiss Med Wkly 132: 51-56.
9. Deborggraeve S, Buscher P, (2010) Molecular diagnostics for sleeping sickness: what is the benefit for the patient? Lancet Infect Dis 10: 433-439.
10. Truc P, Jamonneau V, N'Guessan P, N'Dri L, Diallo PB, et al. (1998) Trypanosoma brucei ssp. and T congolense: mixed human infection in Cote d'Ivoire. Trans R Soc Trop Med Hyg 92: 537-538.
11. Blum J, Beck BR, Brun R, Hatz C, (2005) Clinical and serologic responses to human 'apathogenic' trypanosomes. Trans R Soc Trop Med Hyg 99: 795-797.
12. Boa YF, Traore MA, Doua F, Kouassi-Traore MT, Kouassi BE, et al. (1988) [The different present-day clinical picture of human African trypanosomiasis caused by T. b. gambiense. Analysis of 300 cases from a focus in Daloa, Ivory Coast]. Bull Soc Pathol Exot Filiales 81: 427-444.
13. Bertrand E, Serie F, Kone I, Rive J, Campaore P, et al. (1973) Symptomatologie générale de la trypanosomiase humaine africaine au moment du dépistage. Médecine d'Afrique Noire 20: 303-314.
14. Boatin BA, Wyatt GB, Wurapa FK, Bulsara MK, (1986) Use of symptoms and signs for diagnosis of Trypanosoma brucei rhodesiense trypanosomiasis by rural health personnel. Bull World Health Organ 64: 389-395.
15. Wellde BT, Chumo DA, Reardon MJ, Mwangi J, Asenti A, et al. (1989) Presenting features of Rhodesian sleeping sickness patients in the Lambwe Valley, Kenya. Ann Trop Med Parasitol 83 (Suppl 1): 73-89.
16. Kuepfer I, Hhary EP, Allan M, Edielu A, Burri C, et al. (2011) Clinical Presentation of T.b. rhodesiense Sleeping Sickness in Second Stage Patients from Tanzania and Uganda. PLoS Negl Trop Dis 5: e968.
17. Blum JA, Schmid C, Hatz C, Kazumba L, Mangoni P, et al. (2007) Sleeping glands?- The role of endocrine disorders in sleeping sickness (T.b. gambiense Human African Trypanosomiasis). Acta Trop 104: 16-24.
18. Kouchner G, Bouree P, Lowenthal M, (1979) Hepatic involvement in Trypanosoma rhodesiense trypanosomiasis. Bull Soc Pathol Exot Filiales 72: 131-135.
19. Ngandu-Kabeya G, (1976) [Study of the symptomatology of African trypanosomiasis in children (apropos of 24 cases)]. Ann Soc Belg Med Trop 56: 85-93.
20. Blum JA, Schmid C, Burri C, Hatz C, Olson C, et al. (2009) Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment. PLoS Negl Trop Dis 3: e383.
21. Blum JA, Burri C, Hatz C, Kazumba L, Mangoni P, et al. (2007) Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis). Trop Med Int Health 12: 1422-1432.
22. Blum JA, Zellweger MJ, Burri C, Hatz C, (2008) Cardiac involvement in African and American trypanosomiasis. Lancet Infect Dis 8: 631-641.
23. Dupont B, Charmot G, Lapresle C, (1979) [Trypanosomiasis presenting with trypanids and complicated by myopericarditis (author's transl)]. Nouv Presse Med 8: 1579-1581.
24. Quinn TC, Hill CD, (1983) African trypanosomiasis in an American hunter in East Africa. Arch Intern Med 143: 1021-1023.
25. Croft AM, Jackson CJ, Friend HM, Minton EJ, (2006) African trypanosomiasis in a British soldier. J R Army Med Corps 152: 156-160.
26. Damian MS, Dorndorf W, Burkardt H, Singer I, Leinweber B, et al. (1994) Polyneuritis and myositis in Trypanosoma gambiense infection. Dtsch Med Wochenschr 119: 1690-1693.
27. Reincke M, Arlt W, Heppner C, Petzke F, Chrousos GP, et al. (1998) Neuroendocrine dysfunction in African trypanosomiasis. The role of cytokines. Ann N Y Acad Sci 840: 809-821.
28. Reincke M, Allolio B, Petzke F, Heppner C, Mbulamberi D, et al. (1993) Thyroid dysfunction in African trypanosomiasis: a possible role for inflammatory cytokines. Clin Endocrinol (Oxf) 39: 455-461.
29. Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG, (2011) The human african trypanosomiasis control and surveillance programme of the world health organization 2000-2009: the way forward. PLoS Negl Trop Dis 5: e1007.
30. Simarro PP, Jannin J, Cattand P, (2008) Eliminating human African trypanosomiasis: where do we stand and what comes next? PLoS Med 5: e55.
31. Brun R, Blum J, Chappuis F, Burri C, (2010) Human African trypanosomiasis. Lancet 375: 148-159.
32. Jelinek T, Bisoffi Z, Bonazzi L, van Thiel P, Bronner U, et al. (2002) Cluster of African trypanosomiasis in travelers to Tanzanian national parks. Emerg Infect Dis 8: 634-635.
33. Chappuis F, Loutan L, Simarro P, Lejon V, Buscher P, (2005) Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev 18: 133-146.
34. Checchi F, Filipe JA, Haydon DT, Chandramohan D, Chappuis F, (2008) Estimates of the duration of the early and late stage of gambiense sleeping sickness. BMC Infect Dis 8: 16.
35. Le Bras J, Sina G, Triolo N, Trova P, (1977) Symptomatology générale de la trypanosomiase humaine africaine de l'enfant. Med Trop (Mars) 37: 51-61.
36. Buyst H, (1977) The epidemiology of sleeping sickness in the historical Luangwa valley. Ann Soc Belg Med Trop 57: 349-359.
37. Debroise A, Debroise-Ballereau C, Satge P, Rey M, (1968) African trypanosomiasis in young children. Arch Fr Pediatr 25: 703-720.
38. Edan G, (1979) Clinical and biological symptoms of T. gambiense tryponosomiasis in the meningo-encephalitic period (author's transl). Med Trop (Mars) 39: 499-507.
39. Ginoux PY, Frezil JL, Alary JC, (1982) Symptoms of human trypanosomiasis at the first diagnostic phase in the People Republic of Congo (author's transl). Med Trop (Mars) 42: 281-287.
40. Antoine P, (1977) Neurological and psychological studies of patients with sleeping sickness and their course. Ann Soc Belg Med Trop 57: 227-248.
41. Blum J, Nkunku S, Burri C, (2001) Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis. Trop Med Int Health 6: 390-400.
42. Bisser S, Bouteille B, Sarda J, Stanghellini A, Ricard D, et al. (1997) Contribution of biochemical tests in the diagnosis of the nervous phase of human African trypanosomiasis. Bull Soc Pathol Exot 90: 321-326.